Sickle Cell Anemia in Children: Clinical Trials

18 trials for Sickle Cell Anemia in Children, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 4 not yet recruiting, 2 recruiting, 2 unknown. 7 Not applicable, 5 Phase 2, 5 Phase 3, 2 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 3, Not yet recruiting 3, Unknown 1
Phase 25Active not recruiting 1, Completed 1, Recruiting 1, Terminated 1, Unknown 1
Phase 35Completed 3, Recruiting 1, Unknown 1
Phase 12Not yet recruiting 1, Recruiting 1
Phase 41Completed 1

Follow Sickle Cell Anemia in Children: new trials by email Literature Review of Sickle Cell Anemia in Children trials Research Report on Sickle Cell Anemia in Children

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease
Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session - Sickle Cell Disease, Sickle Cell Anemia in Children
Not applicableNot yet recruitingConnecticut Children's Medical Center302027-09-012026-04-29
Buprenorphine for the Management of Pain in Children With Sickle Cell Disease
Buprenorphine Buccal Film [Belbuca] - Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis
Phase 1Not yet recruitingNatasha Archer252027-01-012026-11-04
Hypoxic Red Blood Cells in Sickle Cell Anemia
Hemanext ONE System, Conventional RBCs - Sickle Cell Anaemia, Sickle Cell Anemia Crisis
Not applicableNot yet recruitingHemanext482026-11-302026-11-02
Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease
video intervention, game intervention - Sickle Cell Anemia in Children
Not applicableNot yet recruitingAula Ibrahim abd alrazak1202026-09-012026-09-03
Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
hydroxycarbamide - Sickle Cell Disease, Sickle Cell Anemia in Children
Phase 1 / Phase 2RecruitingChildren's Hospital Medical Center, Cincinnati2502026-05-132026-07-16
Effect of Aquatic Exercises on Muscle Strength and Quality of Life in Children With Sickle Cell Anemia
aquatic exercise in addition to physical exercise, designed physical exercises only - Sickle Cell Anemia in Children
Not applicableCompletedKafrelsheikh University502025-11-012026-01-06
Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa
Hydroxyurea - Sickle Cell Anemia in Children, Sickle Cell Disease
Phase 3RecruitingBrown University4002023-11-152026-08-20
Low Systemic/High Local Exercise Load in Peds SCD
Low systemic strength training, Moderate systemic exercise - Sickle Cell Anemia in Children
Not applicableUnknownUniversity of Mississippi Medical Center602023-09-192024-04-29
The Effect of Voxelotor on Cerebral Hemodynamic Response in Children With Sickle Cell Anemia
Voxelotor - Sickle Cell Anemia in Children
Phase 2TerminatedEmory University222022-03-282025-12-12
Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia
Dihydroartemisinin Piperaquine - Sickle Cell Anemia in Children, Malaria
Phase 3CompletedLiverpool School of Tropical Medicine7232021-04-092023-09-13
Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II )
Hydroxyurea - Sickle Cell Anemia in Children
Phase 3CompletedGlobal Health Uganda LTD2702021-03-092025-04-17
The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria
This study does not entail offering any intervention; all data collected will be based on standard of care. - Sickle Cell Disease, Stroke
CompletedVanderbilt University Medical Center3502020-04-012024-04-23
Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients
Acacia Senegal extract, Pectin - Sickle Cell Anemia in Children
Phase 2 / Phase 3UnknownAl-Neelain University1002020-02-152020-01-28
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
Omega 3, Vit D, Zinc sulfate - Vaso-occlusive Crisis, Sickle Cell Disease
Phase 2 / Phase 3CompletedBeni-Suef University3502019-11-012021-01-27
Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)
Hydroxyurea, Elevated Arm TCD Examination, Normal Arm TCD Examination - Sickle Cell Anemia in Children
Phase 2Active not recruitingChildren's Hospital Medical Center, Cincinnati2022019-04-242026-10-19
PINPOINT: Gaming Technology for SCD Pain
Pinpoint app - Sickle Cell Disease, Sickle Cell Anemia in Children
Not applicableCompletedKlein Buendel, Inc.242018-09-192024-05-01
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Vitamin D3, Standard Vitamin D3 Supplementation - Vitamin D Deficiency, Stem Cell Transplant Complications
Phase 4CompletedPhoenix Children's Hospital492017-11-012020-11-17
Nutritional Outcomes After Vitamin A Supplementation in Subjects With SCD
retinyl palmitate - Sickle Cell Anemia in Children, Vitamin A Deficiency in Children
Not applicableCompletedChildren's Hospital of Philadelphia422015-10-022018-08-16

Narrower conditions

Anemia, Sickle Cell (11)  ·  Vaso-Occlusive Crises (3)  ·  Stroke (2)  ·  Acute Pain (1)  ·  Anemia, Aplastic (1)  ·  Hematologic Diseases (1)  ·  Hemoglobin SC Disease (1)  ·  Malaria (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Neurologic Manifestations (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Vitamin D Deficiency (1)  ·  beta-Thalassemia (1)

Broader conditions

Anemia (12)  ·  Hemic and Lymphatic Diseases (12)  ·  Anemia, Hemolytic (11)  ·  Anemia, Hemolytic, Congenital (11)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (11)  ·  Genetic Diseases, Inborn (11)  ·  Hematologic Diseases (11)  ·  Hemoglobinopathies (11)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)

Interventions

Hydroxyurea (5)  ·  Buprenorphine (1)  ·  Cardiovascular Agents (1)  ·  Cholecalciferol (1)  ·  Docosahexaenoic Acids (1)  ·  Gum Arabic (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Morphine (1)  ·  Pectins (1)  ·  Simvastatin (1)  ·  Zinc Sulfate (1)  ·  retinol palmitate (1)  ·  voxelotor (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (2)  ·  Al-Neelain University (1)  ·  Aula Ibrahim abd alrazak (1)  ·  Beni-Suef University (1)  ·  Brown University (1)  ·  Children's Hospital of Philadelphia (1)  ·  Connecticut Children's Medical Center (1)  ·  Emory University (1)  ·  Global Health Uganda LTD (1)  ·  Hemanext (1)  ·  Kafrelsheikh University (1)  ·  Klein Buendel, Inc. (1)  ·  Liverpool School of Tropical Medicine (1)  ·  Natasha Archer (1)  ·  Phoenix Children's Hospital (1)

Countries

United States (10)  ·  Uganda (3)  ·  Egypt (2)  ·  Angola (1)  ·  Iraq (1)  ·  Malawi (1)  ·  Nigeria (1)  ·  Saudi Arabia (1)  ·  Sudan (1)  ·  Tanzania (1)

Top investigators

Ahmed F Mahmoud Hussein, MS.c (1)  ·  Alexander Ngwube, MD (1)  ·  Amy Tang, MD (1)  ·  Biree Andemariam, MD (1)  ·  Imad M Fdl-Elmula, PhD (1)  ·  Kayla Burgett (1)  ·  Laurel Omert, MD, FACS (1)  ·  Michael R DeBaun, MD, MPH (1)  ·  Nancy Green, MD (1)  ·  Natasha Archer, MD (1)  ·  Patrick T McGann, MD, MS (1)

Results publications

PMID 33305842, PMID 33875811, PMID 35911824, PMID 36870358, PMID 37016392, PMID 37468045, PMID 38364110, PMID 39717517, PMID 39718172, PMID 40085947

NIH funding

K23HL175237 (1), R01HD096559 (1), R44MD010746 (1), U01HL157872 (1)